TCL Archive Clinical Trial Pathology Improvements Recommended By Group Remaining Actions After Merit Review January 12, 1979
TCL Archive New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years October 26, 2012
TCL Archive Talking Back: FDA Faces Challenges Over Avastin & Prostate Cancer Prevention January 21, 2011